Sort
1,049,261 grants matching “t cell”
Presenilin Biology and the Mechanism of Alzheimer's Disease
$2,741,597Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2011 · AG
Morphogenesis and growth of the ventricular wall in development and disease
$2,741,575Anthony B. Firulli · Indiana University Indianapolis · P01 · FY2024 · HL
Chicago WIHS Consortium V (CWC)
$2,741,542Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2017 · AI
What determines the location of meiotic crossovers in the mammalian genome?
$2,741,419Rafael Camerini-Otero · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Protection of Ischemic Myocardium
$2,741,275Roberto Bolli · University Of Louisville · P01 · FY2021 · HL
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$2,741,261Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Pharmacogenomics of Statin Therapy
$2,741,022Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · P50 · FY2016 · GM
Controlling and preventing Asthma progression and Severity in Kids (CASK)
$2,740,791Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2023 · AI
Sex-specific Molecular Profiling to Understand Pathology and Identify Causal Genes and Drug Targets for Alzheimer's Disease
$2,740,705Yunju Sung · Washington University · RF1 · FY2021 · AG
Immune Modulation After Allogeneic HCT
$2,740,234Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2020 · CA
DNA Repair, Mutations and Cellular Aging
$2,740,123Jan No Middle Name Vijg · Albert Einstein College Of Medicine, Inc · P01 · FY2017 · AG
Molecular mechanisms and cellular implications of tau dysfunction
$2,739,985Elizabeth Rhoades · University Of Pennsylvania · RF1 · FY2016 · AG
Multilevel Influences on HIV and Substance Use in a YMSM cohort
$2,739,615Brian Mustanski · Northwestern University At Chicago · U01 · FY2022 · DA
Immune Modulation After Allogeneic HCT
$2,739,426Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,739,423Robert S Negrin · Stanford University · P01 · FY2020 · CA
A Data and Administrative Coordinating Center for the Impact of Genomic Variation on Function Consortium
$2,739,389Joe Michael Cherry · Stanford University · U24 · FY2021 · HG
Cincinnati Comprehensive Sickle Cell Center
$2,739,279Clinton H. Joiner · Cincinnati Childrens Hosp Med Ctr · U54 · FY2007 · HL
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,739,199Weill Medical College Of Cornell Univ · U01 · FY2001 · HL
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,739,199Weill Medical College Of Cornell Univ · U01 · FY2004 · HL
Muscle Disease Unit
$2,739,109Andrew Mammen · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Engineering microbial social interactions: Towards new anti-biofilm therapies
$2,739,000Joao Xavier · Sloan-Kettering Inst Can Research · DP2 · FY2011 · OD
Are multiple tau species toxic in Alzheimer's Disease?
$2,738,635Bradley T Hyman · Massachusetts General Hospital · RF1 · FY2018 · AG
Metabolic factors that control the spectrum of human tuberculosis
$2,738,518David Branch Moody · Brigham And Women'S Hospital · U19 · FY2015 · AI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer
$2,738,466David John Hunter · Harvard School Of Public Health · U19 · FY2010 · CA
Experimental and Clinical Studies of Presbyacusis
$2,737,968Judy R. Dubno · Medical University Of South Carolina · P50 · FY2023 · DC